Allocations
Avaloq, a global provider of Software as a Service (SaaS) and Business Process as a Service (BPaaS) solutions to banks and wealth managers, has launched Avaloq Ventures AG, which will provide access to venture capital funding and growth support for start-ups and fast-growing fintech businesses.
Avaloq Ventures will enable funding for fintechs partnering with Avaloq, e.g. by offering their solutions on Avaloq’s Software Exchange. It will be led by Minho Roth, an alternative investments and fintech entrepreneur with unparalleled experience in funding start-ups. Avaloq Founder and Group Chairman Francisco Fernandez will be Chairman.
Zurich-headquartered Avaloq Ventures will look to
Mid-year figures from Jersey’s regulator show that the Jersey Private Fund structure (JPF), launched last year, is continuing to show strong appeal across alternative asset classes.
According to statistics collated by the Jersey Financial Services Commission (JFSC), 130 JPFs had been established by 30 June this year holding combined total assets under management (AUM) of GBP19.4 billion.
The figures also show that around half of the AUM figure (48 per cent) is attributed to infrastructure, debt and credit funds, whilst hedge funds account for almost a third (29 per cent). Private equity and venture capital funds make up 16
OpenGate Capital, a global private equity firm, has completed the acquisition of AICO, an Italian manufacturer of residential stoves, fireplaces, boilers and cookers from Ambienta SGR, a European private equity group. Terms of the transaction have not been disclosed.
OpenGate Capital Founder and CEO, Andrew Nikou, says: “An integral part of our full potential operational strategy is to drive value into the businesses we acquire through add-on acquisitions that have the potential of offering new products or can provide access to new markets. AICO represents these elements and we are excited with the opportunity to expand on Jøtul’s rising growth
Motive Partners, a global private equity firm focussed on growth investing, has acquired a controlling interest in LPA.
Headquartered in Frankfurt, Germany, and founded in 1999, LPA is a financial technology solutions provider with a focus on capital markets and wealth management participants. LPA offers a broad suite of software to optimise processes and enable regulatory compliance, as well as providing strategic advice and implementation services. The announced transaction follows strong financial results at LPA, with the company having experienced significant revenue and profitability growth in recent years.
LPA’s core products are a suite of technology solutions enabling automated
LSP, a specialist life sciences and health care investment group, has raised more than EUR750 million for three different funds over the past ten months to invest in innovative drug development and medical technology companies across Europe.
This result constitutes a record fundraise in European life sciences, consolidating LSP’s leading position.


2018 has been a landmark year for fundraising in the European life sciences industry. Over EUR3 billion has been raised to date, with institutions being drawn to the non-cyclical nature of the strategy, recognising the enormous potential of the life sciences industry in Europe and increasingly focusing on the
Graycliff Partners has completed the sale of Impakt Holdings to Celestica, a leader in design, manufacturing and supply chain solutions for the world’s most innovative companies, for a total purchase price of approximately USD329 million.
With operations in California and South Korea, Impakt provides design, engineering and agile manufacturing solutions for the display, solar and other capital equipment industries, as well as specialised services that require large format, high-mix complex manufacturing and integration solutions.
Since acquiring Impakt in 2016, Graycliff has teamed with management to identify and execute numerous transformational initiatives to position the company for growth, including building
Da Vinci Capital, an emerging markets private equity firm, has invested in DataArt, a global technology consultancy that designs and develops unique software solutions, to support the company’s growth momentum in key industries.
DataArt will continue to focus on its three key markets: the US, the UK and continental Europe, where Da Vinci Capital has substantial assets and a proven track record, including steering software engineering powerhouse Epam to an initial public offering on the New York Stock Exchange in 2012.
Headquartered in New York City, DataArt employs over 2,500 professionals in 20 locations throughout the US, Europe, and Latin America,
C5 Capital Limited (C5), a venture capital firm focused on investing in cyber security, cloud computing, and artificial intelligence, has led an USD18 million investment round in US and European identity-focussed cyber intelligence company 4iQ.
Around 80 per cent of cybercrime begins with stolen credentials and 4iQ has indexed billions of exposed identities by scanning documents in 26 different languages across search engines and social media. It also investigates deep web sites such as paste bins, hacker forums, irc channels and dark websites. With this information, 4iQ is able to alert individuals and organisations if, and when, their information is
Kinly, a portfolio company of private equity firm Avedon Capital Partners has acquired MK2 in a deal that fits in with Kinly’s strategy of strengthening its position in the audio-visual and visual collaboration market through organic growth and strategic acquisitions.
In recent years, MK2 has rapidly developed from Breda into a market leader in the Netherlands within the field of audio-visual solutions and can count many leading businesses as long-term customers.

Together, Kinly and MK2 are the experts in the Dutch market for IT-driven AV and visual collaboration solutions. Kinly increases its AV knowledge and experience. For MK2 and its
New York-based Blue Ox Healthcare Partners (Blue Ox) is a private equity investment firm providing capital to growth stage healthcare companies. The firm focuses on businesses in the middle market targeting the industry’s transformation to individuality and value-based care in healthcare services, HCIT, and medical and life sciences technologies, whose innovations, strategies and operations are poised for growth.
The firm was established in 2009 by Oded Levy when he left Oracle Partners LP, a hedge fund focused on healthcare investments. At that time, Levy was joined by Sheila H Schweitzer as Co-Founder Managing Partner at Blue Ox, after selling her company
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
